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The Standard for Admissibility of Evidence:
Yesterday and Today
Alan C. Hoffman*
Various state and federal courts across the country have dealt with the
standard for the admissibility of expert testimony and the qualifications of
the individual who proffers the testimony. While any one can seek to be an
expert witness, courts have control of admissibility and thus govern who
ultimately offers testimony and the qualifications of the expert witnesses.
Various jurisdictions have had to deal with the admissibility of scientific
evidence when it comes to fingerprints, systolic blood pressure deception
tests, lie detectors, voice identification, and voice stress analysis. Some of
those tests were based upon other medical or medically developed
principals. This article will focus on the standards that have been created for
the qualifications of an expert, the admissibility of expert testimony and
how some parties have tried to meet the various jurisdictional criteria.
Prior to 1993, there were several standards of admissibility that were
applied to certain scientific evidence. The Frye1 test originated from the
District of Columbia Court of Appeals in a decision rejecting the
admissibility of a blood pressure deception test. Today there is a similar
issue with regard to the use of the fMRI (functional Magnetic Resonance
Imaging) test which was originally developed to determine brain function
and is now being attempted to be used to determine deception. Since Frye,
the United States issued a ruling in Daubert v. Merrell Dow
Pharmaceuticals, Inc.,2 which held that the Federal Rules of Evidence,
specifically Rule 702, govern the admissibility of scientific evidence.
Daubert was followed by Joiner,3 Kumho,4 and United States v. Scheffer5
(involving polygraph testing), which raised the bar for expert testimony.
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1. Frye v. United States, 54 App. D.C. 46, 47, 293 F. 103, 104 (1923).
2. Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 597 (1993).
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This paper will attempt to review the perils and pitfalls that still remain and
how science consistently presents similar situations that must be addressed.
A prior issue was raised regarding the acceptability of PET scan or
SPECT scan results when used for different types of interpretations such as
tumors compared to traumatic brain injury. A PET scan is a relatively
simple procedure and involves the introduction of radioactive isotopes that
are attached to a tagged compound. Brain function is analyzed by
measuring how each area of the brain demonstrates the uptake of the
isotope and may appear as a different color on an image. The scan was
originally developed for what was thought to be certain types of tissue
scanning but was later adopted by some for scanning for traumatic brain
injuries. A SPECT scan is performed using a gamma camera from multiple
angles and a computer is later used to manipulate the results yielding a 3-D
data set. Using a different radiotracer than normal, some have been able to
use exametazime (HMAPO) to make a neuropsychiatric diagnosis. This
diagnosis would certainly be based on different criteria from those
established by the Diagnostic & Statistical Manual, now known as DSM IV.
A new version, DSM V is now in planning and consultation, but to this
author's knowledge, neither DSM IV nor plans for DSM V involve the use
of imaging studies as criteria for determination of a psychiatric or
neuropsychiatric diagnosis. Therefore, one must look to see whether or not
there are two separately recognized schools for making the diagnosis and
whether either school is not valid or out of date. One must also look at the
sensitivity and selectivity for clinical exams such as mental testing and
determine if the results are reproducible with a high enough degree of
confidence. In order to increase the confidence level one must make clinical
and pathological correlations and this allows for some subjective input on
the part of the clinician.
Another issue that has to be addressed is the use of the software that is
used to read and interpret various types of radiographic or other medical
tests. There is now software available that interprets mammograms, x-rays,
CTs and PET scans amongst other medical tests. Who is to be the "expert"
if the software was written in another country but used in various
institutions around the world? What if the software was used for a test other
than what it was developed for? Still another issue is the use of the software
with other "markers" or isotopes that were not meant to be used with the
software which can create an "off-labeling" situation or the ability to use
the test for something that it was not originally designed for.
Another illustration can be shown with worldwide acceptance by both
Daubert and Frye although no national modular accreditation program was
ever in effect until 2008. In 1984, the FONAR Corporation received FDA
approval for its first MRI scanner. In 1991, the fMRI was developed
independently by the University of Minnesota's Center for Magnetic
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Resonance Research. While accreditation standards had previously been in
place, it was not until 2006 that the American College of Radiology (ACR)
approved a resolution that the MRI accreditation program be redesigned
into a modular program which best meets the needs of the MRI practice. At
that time it was determined that Breast MRI be left under breast imaging
and modules were set up for MR Body, MR Head, MR Angiography
(MRA), MR Spine, MR Musculoskeletal and MR Cardiac and that program
finally launched in 2008. The modular program rolled out 24 years after the
first MRI was licensed.
The fMRI was developed based on increased blood flow that
accompanies neural activity in the brain. The resulting local reduction in
deoxyhemoglobin is therefore called an endogenous contrast enhancing
agent or paramagnet. The main advantages of fMRI as a technique to image
brain activity relates to a specific task or sensory type process and includes
the shortness of the scan time, the in-plane resolution of the image and the
fact that the individual undergoing the scan does not require injections of
radioactive isotopes. Of particular importance is the fact that particular
imaging methods and procedures vary from center to center because various
groups have developed their own methods and standards. This is especially
true of those seeking to use fMRI for lie detection, fMRI is currently in use
at various medical centers to study such conditions as neglect syndromes,
cerebella dysfunction, neuro-oncology and similar conditions. Medical
centers have used the fMRI to examine the anatomy of the brain and to
assess the effects of stroke, degenerative disease, or trauma on brain
function and brain mapping in an effort to determine which part of the brain
handles what functions. Some of the centers are still investigational while
others have established their own protocols and are using fMRI in their
facilities.
The criteria established by Daubert and its progeny have articulated four
basic criteria. They are: general acceptability, established standards
controlling the technique's operation and accuracy, a known or potentially
known rate of error, and the testability of the procedure. Can a radiologist
who might testify as to the applicability of those standards be challenged
because he did not do original research work in that area, or should his
testimony be allowed because he relies on computer interpretation or it is
generally accepted even though he is not familiar with how the software
works? In other words, what level of research must an expert be familiar
with in order to testify? This has now become important in the use of the
fMRI in the area of lie detection.
The court in Frye said that the admission of the technique and the
purpose for which it was being used was dependant on its acceptance in the
scientific community. Various courts including numerous state courts
followed Frye but their standard for acceptance varied based upon the
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judicial forum. Daubertv. Merrell Dow Pharmaceuti-als derived a test for
the reliability of scientific evidence from Rule 702. The court held that in
order to qualify as scientific knowledge, an inference or assertion must be
derived by scientific method. The court basically stated that the
requirements for an expert's testimony must pertain to the scientific
knowledge base and establish a standard of evidentiary reliability.
Unanswered questions remain after the advent of the Frye test, including:
at what point is the principle of "sufficiently established" determined; at
what point is a "general acceptance" reached; and what is the definition of
"particular field in which it belongs?" While the Frye test is not applicable
in federal courts, it is applicable in various state courts which still follow
Frye. This allows for inconsistent results between Frye and Daubert
jurisdictions. Federal courts follow Daubert, some state courts follow
Daubert, and still others follow Frye. This creates even more confusion
when courts ascertain a standard for admissibility or determine the criteria
an expert witness or scientific process must meet. If one or two scientists
want to use a test for a certain determination and they testify that the results
can be repeated, do they represent the "scientific community?"
Recently, certain individuals and one or two companies have attempted
to use the fMRI for purposes never before thought possible. They are
seeking to use a medical test developed for brain mapping and neurological
function as a lie detector test. For approximately $5,000 a company will
scan an individual's brain, using an fMRI, to determine if that individual is
telling the truth. The fMRI is used to measure changes in blood flow to
different areas over time. Many fMRI studies have concluded that a few key
areas of the brain are more active during deception than truth telling. Those
areas include the anterior cingulate cortex and the left dorsolateral area as
well as the right anterior prefrontal cortices. Cephos Corporation and No
Lie MRI are two companies in the field. Early in 2008, No Lie MRI and a
defense team were preparing to get the results of the test introduced in a
criminal case in California. The defense team was going to argue that "the
relevant scientific community" is a narrow group consisting only of
scientists who research and develop fMRI based lie detection procedures
with fMRI equipment; in other words, only those scientists who had put the
fMRI to another use. In addition to the limitation of the definition of "the
relevant scientific community," a very interesting medical issue is raised.
The Daubert standards previously cited raised an even higher bar. Shortly
before trial, the defense attorneys decided not to use the test as part of the
evidence they were going to present, and, therefore, a case of first
impression by any court has yet to come.
What if the test is being used for lie detection but an underlying medical
issue is discovered? There was no licensed physician who ordered the test
to whom the results could be reported. Since the test is not being used as a
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medical test, the issue of obtaining medical consent and HIPAA consent are
not relevant and would not be met later down the road. If the findings
indicated a positive medical finding, under what conditions could the
information be disclosed and to whom would these ethical issues be raised?
As demonstrated in this article, there are numerous unanswered questions
waiting to be addressed by various courts before any resolution can come
forward.
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